Follow us...

 

Search News Archives

Monthly Newsletter

 

Lab Bulletin May Newsletter

view the latest issue

Subscribe

News Channels

 

New Laboratory Products

 

Lab News

 

Microscopy & Image Analysis

 

Separation Science

 

Research & Case Studies

 

Literature

 

Videos

 

Events | Webinars

 

 

 

Conferences | Events
bioMérieux

bioMérieux

bioMérieux

Products

Contact bioMérieux


If you have not logged into the website then please enter your details below.

All articles from bioMérieux

  Differential diagnosis of Plasmodium falciparum with bioMérieux’s new VIKIA Malaria Ag Pf/Pan rapid test

bioMérieux has further extended its range of rapid tests for infectious diseases with the launch of VIKIA Malaria Ag Pf/Pan.

VIKIA® Malaria Ag Pf/PanThis qualitative immunochromatographic test differentiates between Plasmodium falciparum and other less virulent malarial species, enabling rapid, effective diagnosis and allowing swift initiation of the appropriate treatment. The VIKIA Malaria Ag Pf/Pan test is an easy-to-use lateral flow assay that enables malarial infections to be detected in whole blood specimens in just 20 minutes, without the need for any additional equipment or specific training....

 

  North Bristol NHS Trust invests in bioMérieux’s BacT/ALERT bioMérieux BacT/ALERT®North Bristol NHS Trust recently chose to award their tender for Pathology Managed Equipment & Consumables Services to Roche Diagnostics Ltd. As part of that tender bioMérieux UK Ltd were chosen to provide a range of automation as part of the Microbiology solution. This included the BacT/ALERT 3D system for both Southmead and Frenchay hospitals, simplifying the integration of the two laboratories.

 

  bioMérieux Awarded NHSBT Contract for Bacterial Screening of Platelets bioMérieux, a world leader in the field of in vitro diagnostics was chosen by National Health Service Blood and Transplant (NHSBT) for bacterial screening of platelets in England and North Wales. During an extensive tender process, a number of technologies for screening platelet products were evaluated and bioMérieux' s BacT/ALERT® 3D for bacterial screening has been chosen.

 

  bioMérieux launches new chromID MRSA medium bioMérieux has recently launched a new version of chromIDTM MRSA chromogenic medium for the detection of methicillin resistant Staphylococcus aureus (MRSA), providing a cost effective solution for rapid routine screening.

 

 

Promotions

 

Media Partners